InflaRx N.V. (IFRX) vs Niagen Bioscience, Inc. (NAGE)

InflaRx N.V. and Niagen Bioscience, Inc. are both Biotechnology companies. InflaRx N.V. and Niagen Bioscience, Inc. are of similar size ($212.2M and $204.2M). InflaRx N.V. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. Niagen Bioscience, Inc. grew revenue faster over the last twelve months: 11.0% against −83.4%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 13 and InflaRx N.V. on 4.

Valuation

Metric IFRX NAGE Biotechnology median
P/E n/m 12.45 8.50
P/S 5,075.70 1.53 9.71
P/B 0.91 2.39 2.13
Price to free cash flow n/m 17.24 20.82
EV/EBITDA 0.71 11.46 0.64
EV/Sales (1,061.22) 1.03 9.21
Earnings yield (43.94%) 8.03% (33.15%)
Free cash flow yield (17.60%) 5.80% (25.50%)

Profitability

Metric IFRX NAGE Biotechnology median
Gross margin (26,762.42%) 64.24% 65.16%
Operating margin 0.00% 8.21% 0.00%
Net margin 0.00% 12.39% 0.00%
Free cash flow margin 0.00% 8.89% 0.00%
Return on equity (38.71%) 21.80% (56.36%)
Return on assets (32.75%) 16.14% (48.04%)
Return on invested capital 0.00% 41.95% 0.00%

Growth

Metric IFRX NAGE Biotechnology median
Revenue growth (TTM) (83.39%) 10.99% 6.02%
EPS growth (last fiscal year) 9.41% 81.82% 30.26%
Revenue growth, 5-year CAGR — 16.91% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IFRX NAGE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.22 6.50 4.72
Net debt to EBITDA 0.97 (3.80) 0.96

Dividend

Metric IFRX NAGE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IFRX NAGE Biotechnology median
Market cap 212.21m 204.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack